There were 1,711 press releases posted in the last 24 hours and 405,185 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image